Maintenance outage: This site will be inaccessible from late evening Mar 7th thru Mar 8th. This is for scheduled technology upgrades by our global hosting service that are affecting numerous websites and online journals. Note that our submission site is still accessible during this period and processing of new submissions will not be affected.
Follow this preprint
Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors
Ana Marcu, Andreas Schlosser, Anne Keupp, Nico Trautwein, Pascal Johann, Matthias Wölfl, Johanna Lager, Camelia Monoranu, Juliane Sarah Walz, Lisa M. Henkel, Jürgen Krauß, Martin Ebinger, Martin Schuhmann, Ulrich Thomale, Torsten Pietsch, Erdwine Klinker, Paul G. Schlegel, Florian Oyen, Yair Reisner, Hans-Georg Rammensee, View ORCID ProfileMatthias Eyrich
doi: https://doi.org/10.1101/2021.06.11.21258679
Now published in Journal for ImmunoTherapy of Cancer doi: 10.1136/jitc-2021-003404
Ana Marcu
1Institute for Cell Biology, Department of Immunology, University of Tübingen, Germany
Andreas Schlosser
2Rudolf-Virchow Zentrum, University of Würzburg, Germany
Anne Keupp
3University Children’s Hospital, University Medical Center Würzburg, Germany
Nico Trautwein
1Institute for Cell Biology, Department of Immunology, University of Tübingen, Germany
Pascal Johann
4DKFZ Heidelberg, Germany
5Swabian Children’s Cancer Center Augsburg, Germany
Matthias Wölfl
3University Children’s Hospital, University Medical Center Würzburg, Germany
Johanna Lager
3University Children’s Hospital, University Medical Center Würzburg, Germany
Camelia Monoranu
6Department of Neuropathology, Institute for Pathology, University of Würzburg, Germany
Juliane Sarah Walz
1Institute for Cell Biology, Department of Immunology, University of Tübingen, Germany
7Cluster of Excellence iFIT (EXC2180), University of Tübingen, Germany
8Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and Robert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany
9Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital of Tübingen, Germany
Lisa M. Henkel
3University Children’s Hospital, University Medical Center Würzburg, Germany
Jürgen Krauß
10Department of Neurosurgery, University Medical Center Würzburg, Germany
Martin Ebinger
11University Children’s Hospital, University Medical Center Tübingen, Germany
Martin Schuhmann
12Department of Neurosurgery, University Medical Center Tübingen, Germany
Ulrich Thomale
13Department of Neurosurgery, Charité, Berlin, Germany
Torsten Pietsch
14Institute of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn, Germany
Erdwine Klinker
15Institute for Transfusion Medicine, University Medical Center Würzburg, Germany
Paul G. Schlegel
3University Children’s Hospital, University Medical Center Würzburg, Germany
Florian Oyen
16University Children’s Hospital, University Medical Center Hamburg Eppendorf, Germany
Yair Reisner
17Department of Immunology, Weizmann Institute of Science, Rehovot, Israel
Hans-Georg Rammensee
1Institute for Cell Biology, Department of Immunology, University of Tübingen, Germany
Matthias Eyrich
3University Children’s Hospital, University Medical Center Würzburg, Germany

Data Availability
All online tools used in this study are publicly available online as indicated including the benign tissue database. Peptide sequence and source protein information are provided in the supplementary materials. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository (doi: 10.1093/nar/gky1106).
Posted June 15, 2021.
Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors
Ana Marcu, Andreas Schlosser, Anne Keupp, Nico Trautwein, Pascal Johann, Matthias Wölfl, Johanna Lager, Camelia Monoranu, Juliane Sarah Walz, Lisa M. Henkel, Jürgen Krauß, Martin Ebinger, Martin Schuhmann, Ulrich Thomale, Torsten Pietsch, Erdwine Klinker, Paul G. Schlegel, Florian Oyen, Yair Reisner, Hans-Georg Rammensee, Matthias Eyrich
medRxiv 2021.06.11.21258679; doi: https://doi.org/10.1101/2021.06.11.21258679
Now published in Journal for ImmunoTherapy of Cancer doi: 10.1136/jitc-2021-003404
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (412)
- Allergy and Immunology (726)
- Anesthesia (214)
- Cardiovascular Medicine (3107)
- Dermatology (263)
- Emergency Medicine (463)
- Epidemiology (13046)
- Forensic Medicine (13)
- Gastroenterology (862)
- Genetic and Genomic Medicine (4866)
- Geriatric Medicine (449)
- Health Economics (751)
- Health Informatics (3068)
- Health Policy (1108)
- Hematology (410)
- HIV/AIDS (962)
- Medical Education (453)
- Medical Ethics (120)
- Nephrology (502)
- Neurology (4631)
- Nursing (247)
- Nutrition (689)
- Oncology (2393)
- Ophthalmology (677)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (306)
- Palliative Medicine (88)
- Pathology (516)
- Pediatrics (1243)
- Primary Care Research (522)
- Public and Global Health (7201)
- Radiology and Imaging (1606)
- Respiratory Medicine (944)
- Rheumatology (460)
- Sports Medicine (403)
- Surgery (514)
- Toxicology (65)
- Transplantation (222)
- Urology (190)